H3K27me3 conditions chemotolerance in triple-negative breast

H3K27me3 conditions chemotolerance in triple-negative breast cancer. - Abstract - Europe PMC

High EZH2 and its target H3K27me3 expression in TNBC predicts poor

Differentiation-state plasticity is a targetable resistance

Molecular and functional profiling of chemotolerant cells unveils

PDF) H3K27me3 conditions chemotolerance in triple-negative breast

Decoding gene regulatory circuitry underlying TNBC chemoresistance

The promise of chromatin research to advance precision medicine - EpiCypher

An EZH2-NF-κB regulatory axis drives expression of pro-oncogenic

The loss of B7-H4 expression in breast cancer cells escaping from T cell cytotoxicity contributes to epithelial-to-mesenchymal transition, Breast Cancer Research

Cancers, Free Full-Text

H3K27me3 conditions chemotolerance in triple-negative breast

H3K27me3 conditions chemotolerance in triple-negative breast

Genetic profiling of chemotolerant and resistant cells All the

Highlights in Cancer Research: November 2022 - The Cancer

Highlights in Cancer Research: November 2022 - The Cancer Researcher